Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Norbert W. Bischofberger, PhD
Age : 61
Public asset : 173,101,267 USD
Linked companies : Gilead Sciences, Inc. - Bayer AG
Dr. Norbert W. Bischofberger is Chief Scientific Officer & Executive VP-Research at Gilead Sciences, Inc.

He is on the Board of Directors at Bayer AG and InCarda Therapeutics, Inc. Dr. Bischofberger was previously employed as Senior Scientist-DNA Synthesis Group by Genentech, Inc.

He received his undergraduate degree from the University of Innsbruck and a doctorate degree from Swiss Federal Institute of Technology.

Current positions of Norbert W. Bischofberger, PhD 
NameTitle Since
Gilead Sciences, Inc.
(Biotechnology & Medical Research)
Chief Scientific Officer & Executive VP-Research 1990
Bayer AG
Member-Supervisory Board 2017
InCarda Therapeutics, Inc. Director 2016

Holdings of Norbert W. Bischofberger, PhD 
Gilead Sciences (GILD)
Biotechnology & Medical Research
2,314,8070.18%173,101,267 USD

Norbert W. Bischofberger, PhD: Personal Network 

Most Read News 
12/11DJROBERT IGER : ConsolidationDisney Deal for Fox Would End Hollywood EraFox Would Play Supporting Role at Disney -- WSJ
12/16 NELSON PELTZ : P&G appoints Peltz to board despite losing proxy battle
12/14 MARTIN BLESSING : UBS puts wealth management in hands of ex-Commerzbank boss Blessing
12/12 CARL ICAHN : Xerox 'desperately' needs new leadership, Icahn says
12/14DJRUPERT MURDOCH : Rupert Murdoch Says Disney Deal Is a Pivot, Not a Retreat
12/15 RUPERT MURDOCH : Murdoch bets live sports and news will boost new, smaller Fox
12/12 RUPERT STADLER : Audi CEO drops plan to sell motorcycle brand Ducati
12/15DJMICHEL LANDEL : Danone Board Proposes Michel Landel as Lead Independent Director
12/11 THOMAS WILSON : Japan's SMBC Nikko poised to poach bankers in push for U.S. growth
12/11 DARA KHOSROWSHAHI : Uber's London license appeal to be heard next year
More news

© 2017 People and Ownership :   
Norbert W. Bischofberger, PhD : Connections 
Institute for Systems Biology
Maverix Biomics, Inc.
Gladstone Foundation (CA)
University of Rochester
Rapidscan Pharma Solutions, Inc.
Asset Management Ventures LLC
Charles Schwab Family of Funds
UCSF Benioff Children's Hospital Oakland
Stanford University
Partners In Health
InCarda Therapeutics, Inc.

Popular Business Leaders 
William Ackman Jean-paul Agon Liliane Bettencourt Jeff Bezos Lloyd Blankfein Vincent Bolloré John Bryant Warren Buffett Kenneth Chenault Gary Cohn Tim Cook Jean Coutu Jamie Dimon Ralph Dommermuth Patrick Drahi John Edwards Douglas Flint Carlos Ghosn Mario Greco David Henry Heinrich Hiesinger Carl Icahn Isabelle Kocher Bruno Lafont Jack Ma Laurent Mignon Lakshmi Mittal James Murdoch Elon Musk Peter Nicholas Michael O'leary Nelson Peltz Hasso Plattner Sumner Redstone Franck Riboud Xavier Rolet Kasper Rorsted Wilbur Ross Sheryl Sandberg George Soros Ulrich Spiesshofer Randall Stephenson Johannes Teyssen François Villeroy De Galhau John Williamson Thomas Wilson Dieter Zetsche Mark Zuckerberg Isabel Dos Santos
A-Z Business Leaders